{
  "state": "nebraska",
  "path": "title-chapter-71-public-health-and-welfare/chapter-71-9603-eligible-patient",
  "sections": [
    {
      "id": "section-71-9603eligible",
      "number": "71-9603.Eligible",
      "heading": "patient.To be an eligible patient under the Investigational Drug Use Act, a person shall:(1) Have an advanced illness, attested by the person's treating physician;(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;(3) Have a recomme",
      "text": "patient.To be an eligible patient under the Investigational Drug Use Act, a person shall:(1) Have an advanced illness, attested by the person's treating physician;(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;(4) Give written, informed consent for the use of the investigational drug, biological product, or device;(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.SourceLaws 2018, LB117, ยง 3.Cross ReferencesHealth Care Facility Licensure Act, see section 71-401.",
      "history": "",
      "source_url": ""
    },
    {
      "id": "section-71-9603",
      "number": "71-9603",
      "heading": "",
      "text": "",
      "history": "",
      "source_url": ""
    }
  ]
}